978. Association of oral anticoagulation therapy with dabigatran and the incidence rate of Staphylococcus aureus bacteremia among patients with atrial fibrillation

BACKGROUND: Dabigatran, a univalent direct thrombin inhibitor, is used as a direct oral anticoagulant (DOAC) for patients with high-risk conditions for thrombosis, such as atrial fibrillation (AF). In-vitro and animal model studies suggest dabigatran (but not other DOACs) might also reduce the virul...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasegawa, Shinya, Ohl, Michael, Vaughan-Sarrazin, Mary, Perencevich, Eli N, Goto, Michihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677642/
http://dx.doi.org/10.1093/ofid/ofad500.033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677642/
http://dx.doi.org/10.1093/ofid/ofad500.033

Ejemplares similares